GRAIL, Inc. (GRAL)
Market Cap | n/a |
Revenue (ttm) | n/a |
Net Income (ttm) | -264.07M |
Shares Out | n/a |
EPS (ttm) | n/a |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | n/a |
Last Price | n/a |
Previous Close | n/a |
Change ($) | n/a |
Change (%) | n/a |
Day's Open | n/a |
Day's Range | n/a |
Day's Volume | n/a |
52-Week Range | n/a |
News
Grail spun out of Illumina in 2015 and has a long-term agreement that requires Grail to give a small percentage of its revenue, whenever it comes, to Illumina.
U.S-based cancer testing startup Grail Inc, which has received funding from Amazon.com Inc founder Jeff Bezos, on Wednesday filed for a U.S. initial public offering.
Every day, energy merchants collect and scrutinize whatever information they can find on fuel demand to get a trading edge: from satellite data tracking oil tankers worldwide to thermal images...
About GRAL
GRAIL is a healthcare company focused on saving lives and improving health by pioneering new technologies for early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. Using our platform technology, we have developed a multi-cancer early detection blood test that has demonstrated in clin... [Read more...]
CEO Hans E. Bishop | Employees 436 |
Stock Exchange NASDAQ | Ticker Symbol GRAL |